Drugs / CL-NK-003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07425483 | Feb → Dec 2026 expected | malignant pancreatic neoplasm | Changhai Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CL-NK-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07425483 ↗ |
| Modality | Cell therapy | “CAR-NK cells (CL-NK-003)” NCT07425483 ↗ |